'Surgeon-tailored' mesh repair resolves urinary incontinence

'Surgeon-tailored' mesh repair resolves urinary incontinence
"Surgeon-tailored" polypropylene mesh repair using a transobturator midurethral sling procedure alone or in combination with pelvic organ prolapse repair is an effective treatment for stress urinary incontinence symptoms, although some concerns remain regarding mesh-related complications, according to a study published in the August issue of Urology.

(HealthDay) -- "Surgeon-tailored" polypropylene mesh (STPM) repair using a transobturator midurethral sling procedure alone or in combination with pelvic organ prolapse repair is an effective treatment for stress urinary incontinence symptoms, although some concerns remain regarding mesh-related complications, according to a study published in the August issue of Urology.

Fikret Fatih Önol, M.D., of the Ümraniye Training and Research Hospital in Istanbul, and colleagues conducted a study involving 52 women with stress urinary incontinence and pelvic who were treated with transobturator midurethral sling alone, and 74 women who received concomitant pelvic organ prolapse repair. One-hundred eighteen women were available for follow-up.

During follow-up the researchers found that 86.4 and 81.1 percent of sling-treated and sling plus pelvic organ prolapse repair patients, respectively, were cured of their stress urinary incontinence. Nearly all (98.6 percent) patients were cured of their pelvic organ prolapse. Preoperative urge symptoms resolved for 53.8 and 62.5 percent of sling and sling plus pelvic organ prolapse repair patients, respectively; however, new urge symptoms developed in 22 and 15 percent, respectively. In 11 patients (14.8 percent) who underwent concomitant pelvic organ prolapse repair vaginal mesh erosions were observed.

"STPM may represent a cost-effective option for stress treatment. Concomitant pelvic organ prolapse repair with STPM does not affect incontinence outcomes and provides high anatomic success and patient satisfaction in the long term," the authors write. "An improved understanding of the risk factors for mesh erosion, development of more bio-compatible implant materials, and better definition of patient selection criteria will define the role of transvaginal surgery for prolapse management in the future."

More information: Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

PISQ-12 validated for patients with pelvic organ prolapse

Mar 03, 2012

(HealthDay) -- The Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12) has been shown to be a valid measure of sexual function in patients who undergo surgical mesh implantation for treatment ...

Researchers offer hope to prolapse sufferers

May 17, 2011

Scientists in Scandinavia have found a new way to treat sufferers of pelvic organ prolapse. Presented in the New England Journal of Medicine, their study reveals that the use of synthetic mesh can have a more ...

Recommended for you

Saudi announces 11 new MERS infections

52 minutes ago

Saudi Arabia on Wednesday announced 11 new cases of MERS, including a 13-year-old child, as its acting health minister vowed to keep the public better informed on the coronavirus.

Homes now 'reservoirs' for superbug MRSA

Apr 21, 2014

An antibiotic-resistant "superbug," long a problem in health-care settings, is now taking up residence in people's homes, a new U.S. study finds.

User comments